Exane Derivatives’s TransUnion TRU Stock Holding History

Exane Derivatives’s Portfolio TRU Stock Details TRU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-19	Closed	-$1.96K	–	943
2022 Q1	$1.96K	Buy	+19	New	+$1.93K	﹤0.01%	754
2021 Q4	–	Sell	-19	Closed	-$2.13K	–	994
2021 Q3	$2.13K	Hold	19	–	–	﹤0.01%	801
2021 Q2	$2.13K	Hold	19	–	–	﹤0.01%	814
2021 Q1	$1.71K	Hold	19	–	–	﹤0.01%	693
2020 Q4	$1.89K	Hold	19	–	–	﹤0.01%	632
2020 Q3	$1.6K	Hold	19	–	–	﹤0.01%	584
2020 Q2	$1.65K	Hold	19	–	–	﹤0.01%	518
2020 Q1	$1.26K	Hold	19	–	–	﹤0.01%	529
2019 Q4	$1.74K	Hold	19	–	–	﹤0.01%	510
2019 Q3	$1.54K	Hold	19	–	–	﹤0.01%	510
2019 Q2	$1.4K	Hold	19	–	–	﹤0.01%	538
2019 Q1	$1.27K	Hold	19	–	–	﹤0.01%	483
2018 Q4	$1.08K	Hold	19	–	–	﹤0.01%	568
2018 Q3	$1.41K	Buy	+19	New	+$1.41K	﹤0.01%	517

Other funds holding TRU

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

IFP

Independent Franchise Partners London, United Kingdom $15.2B AUM 1.56% 1-Year Est. Return

BlueSpruce Investments Chicago, Illinois $650M AUM 19.21% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Exane Derivatives's TRU Position: Q2 2022 in Review

Exane Derivatives sold out of TransUnion (TRU) in Q2 2022, closing a stake of 19 shares — an estimated $1.96K sold.

Exane Derivatives first reported a position in TRU in Q3 2018 and held it in 14 quarters. The position peaked at $2.13K in Q3 2021. 430 funds tracked by Wall St. Rank hold TRU as of Q2 2022.

Exane Derivatives reported no remaining TransUnion position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 19 TransUnion shares in Q2 2022, an estimated $1.96K.
Exane Derivatives first reported a position in TransUnion in Q3 2018 and held it in 14 quarters.
Exane Derivatives's TransUnion position peaked at $2.13K in Q3 2021.
430 funds tracked by Wall St. Rank held TransUnion as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.